55 / 88
55
Wednesday, 21 June 2017
/ Scientific Programme
WFSBP 2017
WED
P-12
POSTER TOUR
13:00–14:30
Congress Hall A 1
Cognitive neuroscience
Chair:
NN
003
Spatial attention modulates conscious somatosen-
sory perception
Deniz Doruk Camsari, USA
L. Chanes, A. Malavera, L. Merabet, A. Valero-Cabre,
F. Fregni
006
Mental fatigue effects cognitive functioning after
acute cardiac events
Julius Burkauskas, Lithuania
A. Bunevicius, J. Brozaitiene, N. A. Fineberg, D. Wellsted,
N. Mickuviene, R. Bunevicius
008
Computer-assisted cognitive remediation in
schizophrenia and Bipolar Disorder BP): A prospective,
randomized, double-blind, sham-controlled study
Chih-Ming Cheng, Taiwan
M.-H. Chen, T.-P. Su, C.-T. Li
009
The effects of varenicline in a ketamine-based rat
model of cognitive dysfunction
Agnieszka Nikiforuk, Poland
A. Potasiewicz, P. Popik
P-13
POSTER TOUR
13:00–14:30
Congress Hall A 1
Sleep & eating disorders
Chair:
Elisabeth Binder, Germany
001
Saccadic control in anorexia nervosa: Implications
for the potential neurobiological underpinnings of
anorexia nervosa
David Castle, Australia
A. Phillipou, S. Rossell, C. Gurvich, L. Abel
002
Eating disorders and psychiatric comorbidity in
ambulatory care: A case series
Maria Marta Jalon Urbina, Spain
A. González Fernández, L. Gómez de Segura Iriarte,
P. González García
004
Physical activity in depressed and non-depressed
patients with obesity
Hubertus Himmerich, United Kingdom
P. Ueck, R. Mergl, G. Gordon, U. Hegerl, C. Sander
005
Kynurenine-pathway and microbial diversity in
anorexia nervosa: Relationship or independency?
Preliminary data
Sabrina Mörkl, Austria
A. Meinitzer, S. Lackner, C. Blesl, A. Painold,
G. Gorkiewicz, K. Kashofer, S. Holasek
006
Subjective sleepiness and objectively measured
EEG-based wakefulness in obese patients and healthy
controls
Hubertus Himmerich, United Kingdom
F. M. Schmidt, M. Murray, N. Albayrak, B. Dalton,
I. C. Campbell, U. Hegerl, C. Sander
009
The role for insomnia and somatic anxiety in the
symptomatology and pharmacotherapy in remitted
depression
Takuya Yoshiike, Japan
Y. Nakasato, K. Kuriyama, M. Nakamura
011
Heart rate variability measures during sleep
distinguish between insomnia and restoring sleep
Thorsten Mikoteit, Switzerland
M. Pawlowski, N. Seiffert, E. Seelig, S. Bilz,
M. Hatzinger, E. Holsboer-Trachsler
012
Sleep loss is associated with medial prefrontal
cortex activity during an emotional distracter task
Annika Dimitrov, Germany
M. Adli, J. Schaake, A. Ligdorf, N. Oei, H. Walter, I. Veer
013
Cerebral metabotropic glutamate receptors of
subtype 5 (mGluR5) are part of the molecular network
regulating sleep need in humans and mice
Sebastian Holst, Denmark
A. Sousek, K. Stingelin, S. S. Moghadam, A. Buck,
S. M. Ametamey, M. Scheidegger, P. Franken, A. Henning,
E. Seifritz, M. Tafti, H.-P. Landolt
P-14
POSTER TOUR
13:00–14:30
Congress Hall A 1
Neurostimulation
Chair:
NN
001
Psychiatric deep brain stimulation: Recurrent and
neglected ethical issues
Laura Cabrera, USA
R. McKenzie, R. Bluhm
002
Invasiveness of deep brain stimulation for
obsessive-compulsive disorder: patient perspective
Simon Raymaekers, Belgium
K. Demyttenaere, L. Luyten, B. Nuttin, L. Gabriels,
C. Bervoets
003
ECT-related anxiety: What have we (not) learned?
Jasmien Obbels, Belgium
E. Verwijk, F. Bouckaert, P. Sienaert
004
Attitudes towards ECT: A survey of Polish mental
health professionals
Anna Antosik-Wójciñska, Poland
G. Gazdag, L. Swiecicki, J. Rybakowski, B. Majtczak,
A. Wichniak